Limited time75% off all plans
Get the app

Neurological Nuclear Medicine

Neurological Nuclear Medicine

Neurological Nuclear Medicine

On this page

Neuro Radiopharm Rx - Brainy Tracers

  • 📌 Mnemonic - Key tracer types: Flow (perfusion), Food (metabolism), Dopamine, Amyloid, Tau (FFDAT).
AgentMechanism/LocalizationKey Clinical Uses
$99mTc$-HMPAO / $99mTc$-ECDCerebral Blood Flow (CBF); lipophilic, trappedStroke, epilepsy (ictal/interictal), brain death, dementia
$18F$-FDGGlucose metabolism; trapped intracellularlyDementia (AD, FTD), epilepsy, brain tumors
$123I$-Ioflupane (DaTscan)Dopamine Transporters (DAT) in striatumParkinsonism (PD vs Essential Tremor), DLB
Amyloid PET (e.g., $18F$-Florbetapir)β-amyloid plaquesAlzheimer's Disease (AD) diagnosis
Tau PET (e.g., $18F$-Flortaucipir)Tau neurofibrillary tanglesAD staging, other tauopathies

Brain Scan Basics - Perfusion & Tumors

  • Cerebral Perfusion (SPECT):
    • Tracers: $99mTc-HMPAO$, $99mTc-ECD$. Lipophilic, cross BBB, trapped, reflect rCBF.
    • Applications:
      • Stroke: Acute ↓perfusion ("cold spot"); later luxury perfusion (↑flow, ↓metabolism).
      • Epilepsy: Ictal ↑perfusion, interictal ↓perfusion at focus.
      • Dementia: Pattern-specific ↓perfusion (e.g., temporoparietal in Alzheimer's).
  • Brain Tumor Imaging (PET/SPECT):
    • $^{18}F-FDG$ PET: Measures glucose metabolism. High-grade tumors: FDG-avid. Differentiates recurrence (hot) vs. radiation necrosis (cold).
    • Amino Acid Tracers (e.g., $^{11}C-MET$, $^{18}F-FET$): Higher tumor specificity vs. inflammation/necrosis than FDG.
    • $^{201}Tl$ SPECT: Uptake in viable tumor, not necrosis.

SPECT brain perfusion: acute stroke vs. luxury perfusion

⭐ Brain death on radionuclide angiography: No intracranial arterial flow - 'hollow skull' or 'empty light bulb' sign.

Mind Matters - Dementia & Epilepsy

  • Dementia Imaging (FDG-PET): Assesses regional cerebral glucose metabolism. Characteristic patterns aid diagnosis.

    Dementia TypeFDG-PET Hypometabolism Pattern
    Alzheimer's Disease (AD)Bilateral temporoparietal, posterior cingulate, precuneus (📌 PTP: Parieto-Temporal, Posterior cingulate)
    Frontotemporal Dem. (FTD)Predominantly frontal and/or anterior temporal lobes
    Lewy Body Dementia (LBD)Occipital hypometabolism (sparing of mid/posterior cingulate: "cingulate island sign")
    Vascular Dementia (VaD)Multiple, asymmetric cortical and/or subcortical areas, often patchy

    FDG-PET: AD vs non-AD hypometabolism patterns

  • Epilepsy Imaging: Localizes epileptogenic foci.

    • Ictal SPECT ($^{99m}$Tc-HMPAO or $^{99m}$Tc-ECD): Shows ↑ perfusion at seizure onset site.

      ⭐ Ictal SPECT is more sensitive than interictal SPECT for localizing epileptogenic foci and requires rapid tracer injection (ideally within 30-60 seconds) during or immediately after seizure onset.

    • Interictal PET (FDG): Reveals ↓ metabolism in the epileptogenic zone.
    • Interictal SPECT: Often normal or may show ↓ perfusion in the epileptogenic zone during the interictal phase.

Shakes & Leaks - Movement & CSF

  • Movement Disorders (DaT Imaging):
    • Agents: $123I$-ioflupane (DaTscan), $99mTc$-TRODAT.
    • Mech: Assesses presynaptic dopamine transporter (DaT) integrity in nigrostriatal neurons.
    • Indic: Differentiates PD (DaT deficit) from non-DaT deficit disorders (Essential Tremor, drug-induced parkinsonism).
    • Findings:
      • Normal: Symmetrical, intense "comma"/"crescent" striatal uptake (caudate, putamen).
      • PD: ↓ asymmetric putamen uptake, progressing to "period"/"dot" appearance.
    • DaTscan SPECT: Normal vs Abnormal Striatal Uptake
  • CSF Dynamics (Radionuclide Cisternography):
    • Agent: $111In$-DTPA / $99mTc$-DTPA (intrathecal).
    • CSF Leak Detection:
      • Method: Nasal/ear pledgets vs. serum activity.
      • Positive: Pledget/serum ratio > 1.5-2.0; or direct tracer visualization.
    • Normal Pressure Hydrocephalus (NPH):
      • 📌 Clinical triad: "Wet, Wobbly, Wacky".
      • ⭐ NPH Pattern: Early ventricular reflux (2-6h), persistent intraventricular activity at 24-48h, delayed/absent flow over cerebral convexities.

High‑Yield Points - ⚡ Biggest Takeaways

  • SPECT with HMPAO/ECD shows hypoperfusion in ictal epilepsy and interictal stroke/dementia.
  • FDG-PET reveals hypometabolism: temporoparietal (Alzheimer's), frontal (FTD), interictal epileptogenic foci.
  • DaTscan (Ioflupane I-123 SPECT) differentiates Parkinson's disease (↓ striatal uptake) from essential tremor.
  • Brain death scintigraphy (Tc-99m HMPAO/ECD) shows absent intracranial flow ("empty light bulb" sign).
  • Amyloid PET imaging (e.g., Florbetapir F-18) detects amyloid plaques in Alzheimer's disease.
  • CSF leak studies use In-111 DTPA or Tc-99m DTPA to detect rhinorrhea/otorrhea.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE